| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 14 |
| 1 | LEUPROLIDE ACETATE | 13 |
| 2 | DOCETAXEL | 12 |
| 3 | DOCETAXEL ANHYDROUS | 12 |
| 4 | CAPECITABINE | 11 |
| 5 | CARBOPLATIN | 6 |
| 6 | MITOMYCIN | 4 |
| 7 | FLUOROURACIL | 3 |
| 8 | FLUOROURACIL CREAM, 0.5% | 3 |
| 9 | GEMCITABINE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MITOMYCIN | 4 | 0.0011 |
| 1 | TRIPTORELIN | 1 | 0.0003 |
| 2 | THIOTEPA | 2 | 0.0002 |
| 3 | MANNITOL | 1 | 0.0002 |
| 4 | CISPLATIN | 14 | 0.0002 |
| 5 | DOCETAXEL ANHYDROUS | 12 | 0.0002 |
| 6 | DOCETAXEL | 12 | 0.0002 |
| 7 | ISATUXIMAB | 1 | 0.0002 |
| 8 | LEUPROLIDE ACETATE | 13 | 0.0002 |
| 9 | EPIRUBICIN HYDROCHLORIDE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 2 | Microtubule Inhibitor [EPC] | 15 | 0.0001 |
| 3 | Platinum-based Drug [EPC] | 19 | 0.0001 |
| 4 | Androgen Receptor Inhibitor [EPC] | 3 | 0.0000 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 11 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 8 | 0.0000 |
| 7 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Proteasome Inhibitor [EPC] | 1 | 0.0000 |